The effect of exogenous GM1 ganglioside on kindled-amygdaloid seizures

Timothy E Albertson, W. F. Walby

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The effects of 12 daily doses of 30mg/kg GM1 ganglioside i.p. on the acquisition of kindled-amygdaloid seizures in the rat was studied. No modification in the rate of kindling or the expression of the elicited seizures was noted during the acquisition phase. Further studies with additional fully amygdaloid kindled rats failed to show significant modification of suprathreshold or threshold elicited seizures after single 30-60mg/kg i.p. doses of GM1 ganglioside. Despite previous studies which have shown antibodies to GM1 ganglioside to be convulsive, no anticonvul sant activity was demonstrated in this study with exogenous GM1 ganglioside using a battery of kindled-amygdaloid seizure tests in the rat.

Original languageEnglish (US)
Pages (from-to)261-264
Number of pages4
JournalNeuropharmacology
Volume26
Issue number2-3
DOIs
StatePublished - 1987

Fingerprint

G(M1) Ganglioside
Seizures
Epilepsy
Antibodies

Keywords

  • Amygdala
  • ganglioside
  • GM
  • kindling
  • seizures

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

The effect of exogenous GM1 ganglioside on kindled-amygdaloid seizures. / Albertson, Timothy E; Walby, W. F.

In: Neuropharmacology, Vol. 26, No. 2-3, 1987, p. 261-264.

Research output: Contribution to journalArticle

@article{05df895b9ae54b7f9e0c7c85ec15e51e,
title = "The effect of exogenous GM1 ganglioside on kindled-amygdaloid seizures",
abstract = "The effects of 12 daily doses of 30mg/kg GM1 ganglioside i.p. on the acquisition of kindled-amygdaloid seizures in the rat was studied. No modification in the rate of kindling or the expression of the elicited seizures was noted during the acquisition phase. Further studies with additional fully amygdaloid kindled rats failed to show significant modification of suprathreshold or threshold elicited seizures after single 30-60mg/kg i.p. doses of GM1 ganglioside. Despite previous studies which have shown antibodies to GM1 ganglioside to be convulsive, no anticonvul sant activity was demonstrated in this study with exogenous GM1 ganglioside using a battery of kindled-amygdaloid seizure tests in the rat.",
keywords = "Amygdala, ganglioside, GM, kindling, seizures",
author = "Albertson, {Timothy E} and Walby, {W. F.}",
year = "1987",
doi = "10.1016/0028-3908(87)90217-6",
language = "English (US)",
volume = "26",
pages = "261--264",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "2-3",

}

TY - JOUR

T1 - The effect of exogenous GM1 ganglioside on kindled-amygdaloid seizures

AU - Albertson, Timothy E

AU - Walby, W. F.

PY - 1987

Y1 - 1987

N2 - The effects of 12 daily doses of 30mg/kg GM1 ganglioside i.p. on the acquisition of kindled-amygdaloid seizures in the rat was studied. No modification in the rate of kindling or the expression of the elicited seizures was noted during the acquisition phase. Further studies with additional fully amygdaloid kindled rats failed to show significant modification of suprathreshold or threshold elicited seizures after single 30-60mg/kg i.p. doses of GM1 ganglioside. Despite previous studies which have shown antibodies to GM1 ganglioside to be convulsive, no anticonvul sant activity was demonstrated in this study with exogenous GM1 ganglioside using a battery of kindled-amygdaloid seizure tests in the rat.

AB - The effects of 12 daily doses of 30mg/kg GM1 ganglioside i.p. on the acquisition of kindled-amygdaloid seizures in the rat was studied. No modification in the rate of kindling or the expression of the elicited seizures was noted during the acquisition phase. Further studies with additional fully amygdaloid kindled rats failed to show significant modification of suprathreshold or threshold elicited seizures after single 30-60mg/kg i.p. doses of GM1 ganglioside. Despite previous studies which have shown antibodies to GM1 ganglioside to be convulsive, no anticonvul sant activity was demonstrated in this study with exogenous GM1 ganglioside using a battery of kindled-amygdaloid seizure tests in the rat.

KW - Amygdala

KW - ganglioside

KW - GM

KW - kindling

KW - seizures

UR - http://www.scopus.com/inward/record.url?scp=0023160285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023160285&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(87)90217-6

DO - 10.1016/0028-3908(87)90217-6

M3 - Article

C2 - 3587534

AN - SCOPUS:0023160285

VL - 26

SP - 261

EP - 264

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 2-3

ER -